Navigation Links
Phase 1 Trial of Whole-Parasite Malaria Vaccine to Begin
Date:4/22/2009

eams at the Center for Vaccine Development and the Naval Medical Research Center -- findings that were never translated into a vaccine development effort because the task was considered to be impossible."

Sanaria Inc. was founded in 2003. The company's primary mission is to develop and commercialize a malaria sporozoite vaccine against Plasmodium falciparum, the parasite responsible for more than 95 percent of malaria-associated severe illness and death world-wide, and the malaria parasite for which there is the most significant drug resistance. Sanaria has overcome the initial technological and regulatory barriers with support from many partners and colleagues, including those at the National Institute of Allergy and Infectious Diseases, the US Military Malaria Vaccine Program, the US Army Military Infectious Diseases Research Program, the Institute for One World Health, the PATH Malaria Vaccine Initiative, and the University of Maryland School of Medicine Center for Vaccine Development. Sanaria's facilities are in Rockville, MD. For more information, see www.sanaria.com.

Except for historical information, this news release contains certain forward-looking statements that involve known and unknown risk and uncertainties, which may cause actual results to differ materially from any future results, performance or achievements expressed or implied by the statements made. Such statements include the assessment of the vaccine candidate, expectations for the number and timing of the inoculation of study subjects, the expectations for immunity of the vaccine, and belief concerning the measure of success. These forward-looking statements are further qualified by important factors that could cause actual results to differ materially from those in the forward-looking statements. These factors include, without limitation, the Company's ability to raise sufficient fund
'/>"/>

SOURCE Sanaria Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. BioMarin Initiates Phase 1/2 Clinical Trial for GALNS for Morquio A Syndrome
2. ImQuest BioSciences Receives Phase I SBIR Grant to Develop a Novel Hepatitis C Virus Therapeutic Agent
3. Dendreon Initiates Phase 1 Clinical Trial of Small Molecule Targeting TRPM8 in Cancer
4. Circassias Allergy Therapy Begins Phase II Clinical Trial in Asthma Patients
5. Elusys Anthrax Anti-Toxin, Anthim(TM), Enters Second Phase I Clinical Study
6. Peregrine Pharmaceuticals Reports Positive Preliminary Data From Phase II Bavituximab Lung Cancer Trial
7. VentiRx Pharmaceuticals Initiates Phase I Clinical Trial of VTX-1463, a Novel TLR8 Agonist for the Treatment of Allergic Rhinitis
8. Novagali Pharma Completed a New Phase II With Cyclokat(R) in Dry Eye
9. Pfizer and Medivation Initiate Phase 3 Trial of Dimebon Added to Donepezil in Patients with Alzheimers Disease
10. Osprey Pharmaceuticals U.S.A., Inc. Initiates Phase Ib Clinical Trial in IgA Nephropathy
11. Dendreon to Hold a Conference Call Tomorrow at 9:00 AM ET to Discuss Final Results of Phase 3 PROVENGE IMPACT Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2015)... , August 27, 2015 According ... Market by Type (Integrated, Standalone), by Deployment Mode (Web ... Physicians, Emergency Healthcare Service Providers), by Component - Global ... Systems Market is estimated at $501.1 Million 2014, and ... a CAGR of 7.6% from 2014 to 2019. ...
(Date:8/27/2015)... 2015  BioElectronics Corporation (OTC Pink: BIEL), the maker ... abstracts featuring the use of ActiPatch®, its novel musculoskeletal ... Congress of the European Pain Federation EFIC®, ... 2015. The Company will also be exhibiting at the ... Bagnato , department clinical and experimental rheumatology from the ...
(Date:8/27/2015)... --  Americord Registry , a private cord blood ... banking company, announced today the launch of their ... website makes the expecting parent,s cord blood banking purchase ... checkout process. Logo - http://photos.prnewswire.com/prnh/20150827/261520LOGO ... this service difficult to purchase online. We want to ...
Breaking Medicine Technology:Radiology Information Systems Market Worth $722.7 Million by 2019 2Radiology Information Systems Market Worth $722.7 Million by 2019 3Radiology Information Systems Market Worth $722.7 Million by 2019 4BioElectronics Selected to Present its Pain Research and Devices at the European Pain Federation Conference 2Cord Blood Bank Revolutionizes Process of Online Cord Blood Banking 2
... Va., Nov. 16 As a two-time cancer survivor, Bill Still ... Sentara Cancer Network first-hand. When Bill,s prostate cancer ... group with the help of a community outreach nurse at Sentara ... care delivery system, he was largely on his own. , Bill ...
... , MAPLE GROVE, Minn., Nov. 16 ... Treatment of L ipoproteins and I nflammatory ... Journal of Clinical Lipidology . The objective was to ... and Lipitor (atorvastatin calcium) 10 mg/day, given alone and then ...
Cached Medicine Technology:Sentara Cancer Network Earns National Accreditation 2New Data: Cholesterol Management Analysis of Upsher-Smith's Slo-Niacin(R) Tablets in Combination with Lipitor(R) 2New Data: Cholesterol Management Analysis of Upsher-Smith's Slo-Niacin(R) Tablets in Combination with Lipitor(R) 3New Data: Cholesterol Management Analysis of Upsher-Smith's Slo-Niacin(R) Tablets in Combination with Lipitor(R) 4
(Date:8/27/2015)... ... August 27, 2015 , ... Allegheny General Hospital ... 20 adult-only medical centers in the United States to receive international recognition for ... The Extracorporeal Life Support Organization (ELSO) , an international consortium of healthcare ...
(Date:8/27/2015)... ... August 27, 2015 , ... About 10 percent ... into the Gulf Coast, killing more than 1,800 people, displacing hundreds of thousands ... Georgia State University study. , While most people don’t develop persistent depression after ...
(Date:8/27/2015)... CA (PRWEB) , ... August 27, 2015 , ... ... & IoT Summit , scheduled for October 27-29, 2015 in San Jose, CA. ... the summit will primarily focus on the void that exists where battery development ...
(Date:8/27/2015)... ... August 27, 2015 , ... Zensah®, the premium ... Tennis player for Israel in the Women’s Tennis Association (WTA). Glushko competes in ... and recovery. , With a focus on technology and comfort, Zensah® has developed ...
(Date:8/27/2015)... CITY, Tenn. (PRWEB) , ... August 27, 2015 , ... ... LLC, DBA All Clear System. The agreement will enable both Johnson City, Tenn.-based firms ... All Clear System is a cloud-based safety product that caters to organizations in the ...
Breaking Medicine News(10 mins):Health News:International Organization Honors Allegheny General Hospital's Advanced Lifesaving Program for Cardiac and Respiratory Failure 2Health News:International Organization Honors Allegheny General Hospital's Advanced Lifesaving Program for Cardiac and Respiratory Failure 3Health News:International Organization Honors Allegheny General Hospital's Advanced Lifesaving Program for Cardiac and Respiratory Failure 4Health News:About 10 Percent of Mothers Experienced Depression Two Years After Hurricane Katrina, New Study Shows 2Health News:Infocast Hosting First Conference Dedicated to Powering Wearable Devices & the IoT 2Health News:Zensah® Compression Announces Partnership with WTA Tennis Professional Athlete, Julia Glushko 2Health News:Zensah® Compression Announces Partnership with WTA Tennis Professional Athlete, Julia Glushko 3Health News:Banc Intranets Forms Strategic Marketing Partnership with All Clear System 2Health News:Banc Intranets Forms Strategic Marketing Partnership with All Clear System 3Health News:Banc Intranets Forms Strategic Marketing Partnership with All Clear System 4
... Ind., Feb. 27 Zimmer Holdings, Inc. (NYSE: ... N. Casper, Executive Vice President and Chief Operating Officer ... its Board of Directors. Thermo Fisher Scientific, the ... equipment, supplies and services used in life sciences, healthcare, ...
... System, as Inventor of the Month for February 2009SAN ... ADSK ) has named Cochlear Bone Anchored Solutions, a ... in the development and manufacturing of implantable hearing solutions, ... February 2009.Cochlear successfully used Autodesk Inventor software ...
... by Communion and Liberation: D A T E: Friday, February 27, 2009 ... Gowan Hall ( Nursing-Biology Building ), ... 620 Michigan Avenue NE , Washington , ... Different Way of Facing H.I.V. -- From Sickness and Despair to a New Life: ...
... a Highly Effective and Affordable New Option to Help ... Derma Sciences, Inc. (OTC Bulletin ... announced today that its first BIOGUARD Barrier Dressings have ... for marketing and distribution. BIOGUARD will offer surgeons, ...
... Novalar Pharmaceuticals, Inc., a dental specialty pharmaceutical ... company,s premier dental pharmaceutical product. OraVerse is the ... accelerates the return to normal sensation and function ... and unnecessary lingering soft tissue anesthesia following routine ...
... University of Pittsburgh Medical Center (UPMC) and Paphos Plantations Ltd. (PPL) - ... collaborating to develop a world-class health care center in Paphos, Cyprus, designed ... and foreign visitors to this Mediterranean island. , ... Pittsburgh, PA and ...
Cached Medicine News:Health News:Zimmer Holdings Names Marc Casper to Board of Directors 2Health News:Zimmer Holdings Names Marc Casper to Board of Directors 3Health News:Superior Sound Amplifies Quality of Life for the Deaf and Hard of Hearing 2Health News:Superior Sound Amplifies Quality of Life for the Deaf and Hard of Hearing 3Health News:Superior Sound Amplifies Quality of Life for the Deaf and Hard of Hearing 4Health News:Derma Sciences Gains FDA Clearance for Novel BIOGUARD(TM) Barrier Dressing with NIMBUS(R) Technology 2Health News:Derma Sciences Gains FDA Clearance for Novel BIOGUARD(TM) Barrier Dressing with NIMBUS(R) Technology 3Health News:Derma Sciences Gains FDA Clearance for Novel BIOGUARD(TM) Barrier Dressing with NIMBUS(R) Technology 4Health News:Video: Novalar Announces the Launch of OraVerse(TM) the First Dental Anesthesia Reversal Agent 2Health News:Video: Novalar Announces the Launch of OraVerse(TM) the First Dental Anesthesia Reversal Agent 3Health News:Video: Novalar Announces the Launch of OraVerse(TM) the First Dental Anesthesia Reversal Agent 4Health News:University of Pittsburgh Medical Center to Manage New Health Center in Cyprus 2Health News:University of Pittsburgh Medical Center to Manage New Health Center in Cyprus 3Health News:University of Pittsburgh Medical Center to Manage New Health Center in Cyprus 4
The Snap-In Snap-Out-II Tip Inserts offer a large variety of configurations....
The ACMI™ line of laparoscopic hand instruments is designed to provide a wide selection of popular surgical devices to meet procedural needs....
This probe coagulates bleeders while suction channel with trumpet valve simultaneously evacuates smoke....
Bair Hugger temperature management units are the only forced-air warming systems that can be used with an integrated, cost-effective method of fluid warming...
Medicine Products: